A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03296163 · COMPLETED
Trial details
- NCT number
- NCT03296163
- Sponsor
- mAbxience Research S.L.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2019-07-03
- Enrollment
- 627
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.